ArticleCurrent gene therapy2015

Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.

Olivier Negre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.